Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

PubWeight™: 11.64‹?› | Rank: Top 0.1%

🔗 View Article (PMID 17446442)

Published in Circulation on April 19, 2007

Authors

Walter Wilson1, Kathryn A Taubert, Michael Gewitz, Peter B Lockhart, Larry M Baddour, Matthew Levison, Ann Bolger, Christopher H Cabell, Masato Takahashi, Robert S Baltimore, Jane W Newburger, Brian L Strom, Lloyd Y Tani, Michael Gerber, Robert O Bonow, Thomas Pallasch, Stanford T Shulman, Anne H Rowley, Jane C Burns, Patricia Ferrieri, Timothy Gardner, David Goff, David T Durack, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, American Heart Association Council on Cardiovascular Disease in the Young, American Heart Association Council on Clinical Cardiology, American Heart Association Council on Cardiovascular Surgery and Anesthesia, Quality of Care and Outcomes Research Interdisciplinary Working Group

Author Affiliations

1: Mayo Clinic, USA.

Associated clinical trials:

Randomized Controlled Trial Comparing Long and Short Duration of Antibiotic Prophylaxis for Patients Undergoing Sinus Lift Surgery | NCT02764710

Articles citing this

(truncated to the top 100)

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Bacteremia associated with toothbrushing and dental extraction. Circulation (2008) 3.71

Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy. Can J Gastroenterol (2012) 3.15

Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines. Circulation (2012) 2.97

NICE and antibiotic prophylaxis to prevent endocarditis. Br Dent J (2015) 2.88

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ (2011) 2.61

Guidelines on prophylaxis to prevent infective endocarditis. Br Dent J (2016) 2.49

Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc (2009) 2.23

Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am (2007) 2.17

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant (2011) 2.11

Comparison of Azithromycin and Amoxicillin Before Dental Implant Placement: An Exploratory Study of Bioavailability and Resolution of Postoperative Inflammation. J Periodontol (2015) 2.03

Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev (2013) 2.01

Routine screening for depression in patients with coronary heart disease never mind. J Am Coll Cardiol (2009) 1.99

A call to action for antimicrobial stewardship in the emergency department: approaches and strategies. Ann Emerg Med (2012) 1.80

Aftercare for patients with transplanted organs. Dtsch Arztebl Int (2009) 1.72

Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis. J Antimicrob Chemother (2015) 1.71

Microbiology of odontogenic bacteremia: beyond endocarditis. Clin Microbiol Rev (2009) 1.71

Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis (2011) 1.70

Infective endocarditis in the U.S., 1998-2009: a nationwide study. PLoS One (2013) 1.68

Valvular heart disease: diagnosis and management. Mayo Clin Proc (2010) 1.65

Antibiotic prescribing practices by dentists: a review. Ther Clin Risk Manag (2010) 1.57

Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa. Heart (2007) 1.50

A model for dental practice in the 21st century. Am J Public Health (2011) 1.48

General principles of antimicrobial therapy. Mayo Clin Proc (2011) 1.42

Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome. Can J Cardiol (2010) 1.40

A change in the NICE guidelines on antibiotic prophylaxis. Br Dent J (2016) 1.40

To close or not to close: the very small patent ductus arteriosus. Congenit Heart Dis (2010) 1.31

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant (2012) 1.28

Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int (2012) 1.28

Anaesthetic considerations in children with congenital heart disease undergoing non-cardiac surgery. Indian J Anaesth (2012) 1.27

Infective endocarditis: rationale for revised guidelines for antibiotic prophylaxis. Clin Med Res (2009) 1.25

Antibiotic prophylaxis of endocarditis: the rest of the world and NICE. J R Soc Med (2011) 1.24

Indications of antibiotic prophylaxis in dental practice- review. Asian Pac J Trop Biomed (2012) 1.23

CUA Guidelines on antibiotic prophylaxis for urologic procedures. Can Urol Assoc J (2015) 1.23

The endoscopy Global Rating Scale-Canada: development and implementation of a quality improvement tool. Can J Gastroenterol (2013) 1.18

Molecular methods for diagnosis of infective endocarditis. Infect Dis Clin North Am (2002) 1.17

Infective endocarditis in congenital heart disease. Eur J Pediatr (2011) 1.15

Changes in clinical and microbiological periodontal profiles relate to progression of carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology study. J Am Heart Assoc (2013) 1.10

Contribution of lipoproteins and lipoprotein processing to endocarditis virulence in Streptococcus sanguinis. J Bacteriol (2009) 1.09

Two Arginine Residues of Streptococcus gordonii Sialic Acid-Binding Adhesin Hsa Are Essential for Interaction to Host Cell Receptors. PLoS One (2016) 1.08

Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol (2010) 1.07

Retracted A rare cause for primary amenorrhoea. J Hum Reprod Sci (2012) 1.06

Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol (2009) 1.04

Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS One (2011) 1.04

Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. J Am Coll Cardiol (2013) 1.02

Successful anesthetic management of a child with blepharophimosis syndrome and atrial septal defect for reconstructive ocular surgery. J Anaesthesiol Clin Pharmacol (2011) 1.02

Acute infective endocarditis. Infect Dis Clin North Am (2009) 1.01

Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions. Can J Cardiol (2010) 1.00

Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: shunt lesions. Can J Cardiol (2010) 0.99

Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management. Genet Med (2008) 0.98

Transoesophageal echocardiography related complications. Indian J Anaesth (2009) 0.98

Surgery in current therapy for infective endocarditis. Vasc Health Risk Manag (2011) 0.97

Infective endocarditis--prophylaxis, diagnostic criteria, and treatment. Dtsch Arztebl Int (2009) 0.97

Characterizing traditionally defined periodontal disease in HIV+ adults. Community Dent Oral Epidemiol (2009) 0.97

[Heart diseases in pregnancy]. Clin Res Cardiol (2008) 0.96

Late bacterial endocarditis of an Amplatzer atrial septal device. Indian Heart J (2013) 0.95

Congenitally corrected transposition. Orphanet J Rare Dis (2011) 0.95

Characterization of TEM-1 β-lactamase producing Kingella kingae clinical isolates. Antimicrob Agents Chemother (2013) 0.94

Bacteremia and endotoxemia after endoscopic submucosal dissection for gastric neoplasia: pilot study. Gastric Cancer (2011) 0.93

Complete Atrioventricular Block due to Infective Endocarditis of Bicuspid Aortic Valve. J Cardiovasc Ultrasound (2011) 0.93

Evaluation and management of perianal abscess and anal fistula: a consensus statement developed by the Italian Society of Colorectal Surgery (SICCR). Tech Coloproctol (2015) 0.93

Preoperative medical evaluation: part 1: general principles and cardiovascular considerations. Anesth Prog (2009) 0.93

Trends in endocarditis hospitalizations at US children's hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines. Am Heart J (2012) 0.92

Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol (2011) 0.92

Awareness of infective endocarditis prophylaxis in parents of children with congenital heart disease: A prospective survey. Ann Pediatr Cardiol (2008) 0.91

Labour analgesia and anaesthetic management of a primigravida with uncorrected pentalogy of fallot: Few concerns. Indian J Anaesth (2013) 0.91

Marfan syndrome. Part 2: treatment and management of patients. Nat Rev Cardiol (2010) 0.91

Anaesthetic management for drainage of frontoparietal abscess in a patient of uncorrected Tetralogy of Fallot. Indian J Anaesth (2015) 0.89

Antimicrobial prophylaxis in adults. Mayo Clin Proc (2011) 0.88

Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: introduction. Can J Cardiol (2010) 0.88

Heart valve surgery today: indications, operative technique, and selected aspects of postoperative care in acquired valvular heart disease. Dtsch Arztebl Int (2009) 0.87

A pilot study combining individual-based smoking cessation counseling, pharmacotherapy, and dental hygiene intervention. BMC Public Health (2010) 0.87

Prevention of infective endocarditis in developing countries. Cardiovasc J Afr (2012) 0.87

Atrial septal defects - clinical manifestations, echo assessment, and intervention. Clin Med Insights Cardiol (2015) 0.87

Surgical treatment of aortic valve disease. Nat Rev Cardiol (2013) 0.87

[Diagnosis and treatment of infective endocarditis. Current ESC guidelines]. Herz (2010) 0.87

Oral streptococcal bacteremia in hospitalized patients: taxonomic identification and clinical characterization. J Clin Microbiol (2011) 0.86

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther (2012) 0.86

The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects. Curr Cardiol Rev (2010) 0.86

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Rev Bras Hematol Hemoter (2012) 0.86

Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN. Am Heart J (2015) 0.86

Risk factors for pyrexia after endoscopic submucosal dissection of gastric lesions. Endosc Int Open (2014) 0.85

Infective endocarditis prophylaxis: moving from dental prophylaxis to global prevention? Eur J Clin Microbiol Infect Dis (2012) 0.85

The changing epidemiology of pediatric endocarditis at a children's hospital over seven decades. Pediatr Cardiol (2010) 0.85

Dissemination of periodontal pathogens in the bloodstream after periodontal procedures: a systematic review. PLoS One (2014) 0.84

Bacteremia and "Endotipsitis" following transjugular intrahepatic portosystemic shunting. World J Hepatol (2011) 0.84

Risk factors for fluoroquinolone resistance in Enterococcus urinary tract infections in hospitalized patients. Epidemiol Infect (2010) 0.84

The relationship of the lipoprotein SsaB, manganese and superoxide dismutase in Streptococcus sanguinis virulence for endocarditis. Mol Microbiol (2014) 0.84

Antibiotic prophylaxis for dentistry is not associated with fatal anaphylaxis. Clin Med Res (2010) 0.84

Increased systemic elastase and C-reactive protein in aggressive periodontitis (CLOI-D-00160R2). Clin Oral Investig (2011) 0.84

Postoperative care of the facial laceration. Craniomaxillofac Trauma Reconstr (2010) 0.83

Coarctation of the aorta - the current state of surgical and transcatheter therapies. Curr Cardiol Rev (2013) 0.82

Pregnancy complicated by valvular heart disease: an update. J Am Heart Assoc (2014) 0.81

Postpolypectomy Fever, a rare adverse event of polypectomy: nested case-control study. Clin Endosc (2014) 0.81

Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans. Infect Immun (2011) 0.81

The American Heart Association 2007 endocarditis prophylaxis guidelines: a compromise between science and common sense. Can J Cardiol (2008) 0.81

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Role of computerized physician order entry systems in facilitating medication errors. JAMA (2005) 26.32

Universal definition of myocardial infarction. Circulation (2007) 11.69

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2004) 11.41

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation (2005) 10.98

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29

ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation (2006) 9.83

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation (2002) 9.04

Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59

Third universal definition of myocardial infarction. Circulation (2012) 8.47

ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol (2006) 8.36

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med (2006) 8.20

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics (2004) 8.10

AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01

Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98

Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med (2009) 7.82

Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA (2005) 7.41

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 7.41

Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg (2002) 6.92

Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation (2003) 6.47

Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med (2007) 6.22

2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol (2008) 5.99

Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93

2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation (2008) 5.82

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care (2011) 5.63

Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med (2010) 5.43

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care (2008) 5.43

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol (2007) 5.40

Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet (2003) 5.33

Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation (2012) 5.25

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation (2007) 5.20

Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation (2008) 5.15

De novo mutations in histone-modifying genes in congenital heart disease. Nature (2013) 5.15

Hyponatremia among runners in the Boston Marathon. N Engl J Med (2005) 5.14

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke (2006) 5.04

Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation (2007) 4.66

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation (2011) 4.65

Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation (2004) 4.58

Human aortic valve calcification is associated with an osteoblast phenotype. Circulation (2003) 4.49

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2014) 4.34

Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA (2007) 4.27

Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol (2003) 4.27

2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.20

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16

Design of a national distributed health data network. Ann Intern Med (2009) 4.09

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis (2003) 3.93

Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation (2007) 3.90

Neurodevelopmental status at eight years in children with dextro-transposition of the great arteries: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg (2003) 3.85

Physical activity intervention studies: what we know and what we need to know: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity); Council on Cardiovascular Disease in the Young; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Circulation (2006) 3.72

Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation (2006) 3.69

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol (2011) 3.57

Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation (2008) 3.56

The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg (2007) 3.45

Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation (2007) 3.34

Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med (2003) 3.31

Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation (2005) 3.28

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation (2007) 3.27

The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf (2005) 3.24

Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol (2012) 3.24

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Circulation (2003) 3.22

Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension (2008) 3.19

Statin use and the risk of 10 cancers. Epidemiology (2007) 3.17

Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation (2010) 3.17